Literature DB >> 1893616

Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).

N Madi1, G Steiger, J Estreicher, J A Schifferli.   

Abstract

Complement levels and complement receptor 1 (CR1) on erythrocytes (E) are reduced in systemic lupus erythematosus (SLE). To see whether these abnormalities are responsible for defective transport and elimination of immune complexes (IC) from the circulation, patients with active SLE (14) and normal volunteers (14) were injected with preformed IC (hepatitis B surface Ag/Ab). Two minutes after injection only 25.9 +/- 19.1% (mean +/- 1 s.d.) of the circulating IC were bound to E in the SLE patients as compared to 63 +/- 3.7% in the normal subjects (P = 0.0001). For SLE patients, the reduced immune adherence was best explained by a combination of complement depletion and low CR1 binding capacity (tau = 0.80, P = 0.0001). The disappearance of IC as estimated from the area under the elimination curve was faster in SLE than in controls (P = 0.02), and correlated with CR1 (tau = 0.54, P = 0.0001) and immune adherence observed in vivo (tau = 0.33, P = 0.013). Finally, immune adherence was absent and IC disappeared very rapidly in a patient with C2 deficiency and an SLE-like disease. These observations suggest that in SLE the defective immune adherence reaction might be responsible for the accelerated disappearance of IC from the circulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893616      PMCID: PMC1535628          DOI: 10.1111/j.1365-2249.1991.tb05734.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Reduced immune adherence of antigen/antibody complexes formed in the presence of complement in vivo and in vitro.

Authors:  J P Paccaud; G Steiger; J A Schifferli
Journal:  Complement Inflamm       Date:  1989

2.  The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.

Authors:  J A Schifferli; Y C Ng; J Estreicher; M J Walport
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

3.  A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).

Authors:  Y C Ng; D K Peters; S A Cederholm-Williams; M J Walport
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.

Authors:  R P Taylor; E L Wright; F Pocanic
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

5.  Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction.

Authors:  R P Kimberly; N L Meryhew; O A Runquist
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

6.  Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.

Authors:  S Lobatto; M R Daha; A A Voetman; J H Evers-Schouten; A A Van Es; E K Pauwels; L A Van Es
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.

Authors:  F B Waldo; J Forristal; L Beischel; C D West
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

8.  Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.

Authors:  J P Paccaud; G Steiger; A G Sjöholm; P J Spaeth; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

9.  The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.

Authors:  J A Schifferli; Y C Ng; J P Paccaud; M J Walport
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

10.  In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

Authors:  R P Kimberly; J C Edberg; L T Merriam; S B Clarkson; J C Unkeless; R P Taylor
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

View more
  3 in total

1.  Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria.

Authors:  M Odera; W Otieno; C Adhiambo; J A Stoute
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.

Authors:  Daniel J Birmingham; Wei Chen; Grace Liang; Holly C Schmitt; Katie Gavit; Haikady N Nagaraja
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

3.  Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

Authors:  K A Davies; A M Peters; H L Beynon; M J Walport
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.